Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 6/20 | 0.36 |
| ▸ | CTSD | P07339 | 2/20 | 0.36 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.35 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7488273 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL30485088 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL2567128 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL7684896 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL939090 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL8718596 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL30485107 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL1828149 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL20970623 | 1.00 | HCAR3 (0.38) | HCAR3HCAR2ALDH1A1MAPTTDP1 | |
| SCHEMBL19806240 | 0.87 | BACE1 (0.37) | HCAR3HCAR2ALDH1A1MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110997646-B | Process for producing epoxy alcohol compound | 住友化学株式会社 | 2023-06-20 | — | — | CN | disclosed |
| EP-3666762-B1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2022-04-06 | — | — | EP | disclosed |
| US-10730861-B2 | Process for producing epoxy alcohol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-08-04 | — | — | US | disclosed |
| EP-3666762-A1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172520-A1 | PROCESS FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-06-04 | — | — | US | disclosed |
| CN-110997646-A | Method for producing epoxy alcohol compound | 住友化学株式会社 | 2020-04-10 | — | — | CN | disclosed |
| EP-1647551-B1 | OPTICALLY ACTIVE HALOHYDRIN DERIVATIVE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY ALCOHOL DERIVATIVE FROM THE SAME | KANEKA CORP (JP) | 2011-05-04 | — | — | EP | disclosed |
| EP-1892242-B1 | Method of purifying 3-phenyl-3,4-epoxy-2-butanol derivatives by liquid-liquid extraction | SUMITOMO CHEMICAL CO (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-7582781-B2 | epoxidation to produce 1,2-Epoxy-2-(2,4-difluorophenyl)butan-3-ol intermediate for pharmaceutical drugs, a triazole antifungal agent | KANEKA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-7459573-B2 | Method of purifying epoxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-12-02 | — | — | US | disclosed |
| US-20080081921-A1 | Method of purifying epoxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-04-03 | — | — | US | disclosed |
| EP-1892242-A1 | Method of purifying 3-phenyl-3,4-epoxy-2-butanol derivatives by liquid-liquid extraction | Sumitomo Chemical Company, Limited (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-20060155136-A1 | Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same | KANEKA CORPORATION (JP) | 2006-07-13 | — | — | US | disclosed |
| EP-1647551-A1 | OPTICALLY ACTIVE HALOHYDRIN DERIVATIVE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY ALCOHOL DERIVATIVE FROM THE SAME | KANEKA CORPORATION (JP) | 2006-04-19 | — | — | EP | disclosed |
| US-5814324-A | OIL IN WATER EMULSION COMPRISING ANTIFUNGAL TRIAZOLE COMPOUND DISPERSED IN WATER WITH FATTY ACID TRIGLYCERIDE, LECITHIN EMULSIFIER | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-09-29 | — | — | US | disclosed |
| US-5792780-A | FUNGICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155136-A1 | Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same | TALDO1, CYP51A1, ERG28 | HCAR3 172/4885HCAR2 262/4885ALDH1A1 75/4885 |
| US-20080081921-A1 | Method of purifying epoxy compound | RER1, ELP1, AQP1 | HCAR3 3326/4885HCAR2 2035/4885ALDH1A1 297/4885 |
| US-20200172520-A1 | PROCESS FOR PRODUCING EPOXY ALCOHOL COMPOUND | ERG28, CYP2E1, ADH5 | HCAR3 2048/4885HCAR2 1758/4885ALDH1A1 501/4885 |
| US-10730861-B2 | Process for producing epoxy alcohol compound | ERG28, CYP2E1, ADH5 | HCAR3 2048/4885HCAR2 1758/4885ALDH1A1 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.